247 related articles for article (PubMed ID: 32294204)
1. Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.
Beaudoin JJ; Bezençon J; Sjöstedt N; Fallon JK; Brouwer KLR
Toxicol Sci; 2020 Jul; 176(1):34-35. PubMed ID: 32294204
[TBL] [Abstract][Full Text] [Related]
2. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
[TBL] [Abstract][Full Text] [Related]
3. Novel in Vitro Method Reveals Drugs That Inhibit Organic Solute Transporter Alpha/Beta (OSTα/β).
Malinen MM; Kauttonen A; Beaudoin JJ; Sjöstedt N; Honkakoski P; Brouwer KLR
Mol Pharm; 2019 Jan; 16(1):238-246. PubMed ID: 30481467
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.
Beaudoin JJ; Brouwer KLR; Malinen MM
Pharmacol Ther; 2020 Jul; 211():107542. PubMed ID: 32247663
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms.
Guo C; LaCerte C; Edwards JE; Brouwer KR; Brouwer KLR
J Pharmacol Exp Ther; 2018 May; 365(2):413-421. PubMed ID: 29487110
[TBL] [Abstract][Full Text] [Related]
6. Characterization of conjugated and unconjugated bile acid transport via human organic solute transporter α/β.
Suga T; Yamaguchi H; Ogura J; Mano N
Biochim Biophys Acta Biomembr; 2019 May; 1861(5):1023-1029. PubMed ID: 30853579
[TBL] [Abstract][Full Text] [Related]
7. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
[TBL] [Abstract][Full Text] [Related]
9. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
Ali I; Khalid S; Stieger B; Brouwer KLR
Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
[TBL] [Abstract][Full Text] [Related]
11. Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis.
Soroka CJ; Ballatori N; Boyer JL
Semin Liver Dis; 2010 May; 30(2):178-85. PubMed ID: 20422499
[TBL] [Abstract][Full Text] [Related]
12. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
Jackson JP; Brouwer KR
Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
[TBL] [Abstract][Full Text] [Related]
13. The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.
Rao A; Haywood J; Craddock AL; Belinsky MG; Kruh GD; Dawson PA
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3891-6. PubMed ID: 18292224
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
15. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.
Dawson PA; Hubbert M; Haywood J; Craddock AL; Zerangue N; Christian WV; Ballatori N
J Biol Chem; 2005 Feb; 280(8):6960-8. PubMed ID: 15563450
[TBL] [Abstract][Full Text] [Related]
16. Identification of Key Amino Acids that Impact Organic Solute Transporter
Murphy WA; Beaudoin JJ; Laitinen T; Sjöstedt N; Malinen MM; Ho H; Swaan PW; Honkakoski P; Brouwer KLR
Mol Pharmacol; 2021 Dec; 100(6):599-608. PubMed ID: 34599072
[TBL] [Abstract][Full Text] [Related]
17. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
[TBL] [Abstract][Full Text] [Related]
18. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
[TBL] [Abstract][Full Text] [Related]
19. Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver.
Ballatori N; Fang F; Christian WV; Li N; Hammond CL
Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G179-G186. PubMed ID: 18497332
[TBL] [Abstract][Full Text] [Related]
20. Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors.
Saran C; Sundqvist L; Ho H; Niskanen J; Honkakoski P; Brouwer KLR
J Pharmacol Exp Ther; 2022 Feb; 380(2):114-125. PubMed ID: 34794962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
